For more than 30 years, I’ve focused on helping development service companies excel in the drug/device development industry.
Currently, I serve as CEO of RQM+, a leading, global MedTech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product lifecycle.
In March 2016, I co-founded Elligo Health Research, a company focused on enabling patients and clinicians to participate in clinical trials by providing the needed infrastructure not found at all clinical settings. Currently, I serve as Chairperson of the Board.
From 2011 to 2015, I led Theorem Clinical Research as president and CEO, overseeing the company’s strategy, operational execution and customer experience. In September 2015, after record growth, I led the successful sale of Theorem to Chiltern yielding a record ROI for investors.
Prior to joining Theorem, I served as COO at INC Research. While at INC Research, I helped the company achieve record year-over-year profit by upholding a 40 percent CAGR in sales and revenue for several years. Throughout my career, I oversaw multiple acquisitions, providing the operational guidance for the integration of seven major acquisitions in six years. I played a key